• Return to Headlines

Shares of Alexion Pharm Has Risen Above Previous 52-Week High

By Nick Russo

Alexion Pharm (NASDAQ:ALXN) traded at a new 52-week high today of $149.34. Approximately 586,000 shares have changed hands today, as compared to an average 30-day volume of 1.6 million shares.

Alexion Pharmaceuticals, Inc., a biopharmaceutical company, researches and develops proprietary immunoregulatory compounds for the treatment of autoimmune and cardiovascular diseases. The Company develops C5 complement inhibitors and apogens which are two classes of potential therapeutic compounds designed to selectively target specific disease-causing segments of the immune system.

In the past 52 weeks, shares of Alexion Pharm have traded between a low of $96.18 and a high of $149.34 and are now at $145.54, which is 51% above that low price. Over the past week, the 200-day moving average (MA) has gone down 0.8% while the 50-day MA has remained constant.

Potential upside of 6.3% exists for Alexion Pharm, based on a current level of $145.54 and analysts' average consensus price target of $154.72. The stock should hit resistance at its 200-day moving average (MA) of $164.17, as well as support at its 50-day MA of $144.17.

SmarTrend recommended that subscribers consider buying shares of Alexion Pharm on June 12th, 2017 as our proprietary SmarTrend analytics indicated a new Uptrend was in progress when shares hit $106.88. Since that recommendation, shares of Alexion Pharm have risen 34.8%. We continue to monitor ALXN for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.

Keywords: 52 week high/lows alexion pharm

Ticker(s): ALXN